Methods and compositions for treating cancer using peptide nucleic acid-based agents
AssigneeMemorial Sloan Kettering Cancer Center
InventorsJeffery H. Rothman, Gary K. Schwartz
Life of this patent
Estimating the term…
Loading patent…
AssigneeMemorial Sloan Kettering Cancer Center
InventorsJeffery H. Rothman, Gary K. Schwartz
Estimating the term…
The present invention provides compositions and methods for treating cancer with peptide nucleic acid agents. In some embodiments, the present invention provides methods and compositions relating to peptide nucleic acid agents that target oncogenes. For example, the present invention provides compositions, including pharmaceutical compositions, comprising agents specific for BRAF V600E inhibition, or fragments or characteristic portions thereof. The present invention further provides various therapeutic and/or diagnostic methods of using BRAF V600E specific peptide nucleic acid agents and/or compositions.
1-81. (canceled)
A method of reducing expression of a target gene in a cell comprising:
Dependencies are inferred from the claim text.